Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Langlitz

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
History of the Human Sciences|June 4, 2010
The persistence of the subjective in neuropsychopharmacology: observations of contemporary hallucinogen researchNicolas Langlitz
Frontiers in Psychology|February 6, 2023
What good are psychedelic humanities?Nicolas Langlitz
Social Studies of Science|October 24, 2009
Pharmacovigilance and post-black market surveillanceNicolas Langlitz
Progress in Brain Research|August 23, 2017
Opaque models: Using drugs and dreams to explore the neurobiological basis of mental phenomenaNicolas Langlitz
Frontiers in Psychiatry|August 19, 2021
Moral Psychopharmacology Needs Moral Inquiry: The Case of PsychedelicsNicolas Langlitz, Erika Dyck, Milan Scheidegger, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 4, 2005
Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic reviewMazda Adli, Christopher Baethge, Andreas Heinz, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
History of the Human Sciences|June 4, 2010
The persistence of the subjective in neuropsychopharmacology: observations of contemporary hallucinogen researchNicolas Langlitz
Frontiers in Psychology|February 6, 2023
What good are psychedelic humanities?Nicolas Langlitz
Social Studies of Science|October 24, 2009
Pharmacovigilance and post-black market surveillanceNicolas Langlitz
Progress in Brain Research|August 23, 2017
Opaque models: Using drugs and dreams to explore the neurobiological basis of mental phenomenaNicolas Langlitz
Frontiers in Psychiatry|August 19, 2021
Moral Psychopharmacology Needs Moral Inquiry: The Case of PsychedelicsNicolas Langlitz, Erika Dyck, Milan Scheidegger, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 4, 2005
Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic reviewMazda Adli, Christopher Baethge, Andreas Heinz, et al.
Pageof 1